CORCEPT THERAPEUTICS INC - COM (CORT)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
87.1M
Holdings value Q3 2024
$4.03B
Value change Q3 2024
-$43.2M
Grand Portfolio weight change Q3 2024
0%
Number of holders
312
Number of buys Q3 2024
160
Number of sells Q3 2024
-128
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 87.1M $4.03B -$43.2M $46.28 316
2024 Q2 89.2M $2.9B -$102M $32.49 285
2024 Q1 92.8M $2.34B +$181M $25.19 287
2023 Q4 84.7M $2.75B +$89.5M $32.48 273
2023 Q3 82.2M $2.24B +$33.6M $27.25 244
2023 Q2 81.5M $1.81B -$129M $22.25 223
2023 Q1 87.3M $1.89B +$97M $21.66 234
2022 Q4 83.4M $1.69B -$86.2M $20.31 240
2022 Q3 87M $2.23B +$49.3M $25.64 225
2022 Q2 85.1M $2.02B +$98.9M $23.78 213
2022 Q1 81.4M $1.84B +$19.6M $22.52 214
2021 Q4 80.6M $1.59B -$8.21M $19.80 202
2021 Q3 80.9M $1.59B +$4.94M $19.68 197
2021 Q2 80.5M $1.77B -$27.1M $22.00 194
2021 Q1 81.6M $1.94B -$37.9M $23.79 207
2020 Q4 83.4M $2.18B -$130M $26.16 222
2020 Q3 89.2M $1.55B +$5.15M $17.40 218
2020 Q2 89.6M $1.51B +$28.3M $16.82 219
2020 Q1 88.3M $1.05B -$9.56M $11.89 197
2019 Q4 89.1M $1.08B +$45.5M $12.10 202
2019 Q3 85.1M $1.2B -$5.45M $14.13 191
2019 Q2 86.3M $962M -$5.57M $11.15 180
2019 Q1 87.4M $1.03B -$44.1M $11.74 204
2018 Q4 91M $1.22B +$16M $13.36 217
2018 Q3 89.6M $1.26B +$22.2M $14.02 203
2018 Q2 87.6M $1.38B -$4.49M $15.72 216
2018 Q1 87.9M $1.45B -$14.9M $16.45 213
2017 Q4 88.7M $1.6B +$259M $18.06 185
2017 Q3 74.1M $1.43B +$87M $19.30 187
2017 Q2 69.8M $824M +$109M $11.80 154
2017 Q1 60.7M $665M +$151M $10.96 134
2016 Q4 53.3M $387M +$44.1M $7.26 137
2016 Q3 47.2M $307M +$9.9M $6.50 111
2016 Q2 45.7M $250M +$64.9M $5.46 109
2016 Q1 33.9M $159M -$1.37M $4.68 96
2015 Q4 34.2M $170M -$202K $4.98 96
2015 Q3 34.3M $129M +$5.47M $3.76 96
2015 Q2 32.5M $195M +$11.9M $6.01 79
2015 Q1 30.3M $170M +$9.78M $5.60 61
2014 Q4 28.8M $86.3M -$1.42M $3.00 50
2014 Q3 29.3M $78.6M -$1.07M $2.68 54
2014 Q2 29.7M $83.2M -$5.55M $2.80 60
2014 Q1 30.4M $133M +$11.1M $4.36 58